Menu
GWAS Study

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

Juran BD, Hirschfield GM, Invernizzi P et al.

22936693 PubMed ID
GWAS Study Type
7810 Participants
14 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

JB
Juran BD
HG
Hirschfield GM
IP
Invernizzi P
AE
Atkinson EJ
LY
Li Y
XG
Xie G
KR
Kosoy R
RM
Ransom M
SY
Sun Y
BI
Bianchi I
SE
Schlicht EM
LA
Lleo A
CC
Coltescu C
BF
Bernuzzi F
PM
Podda M
LC
Lammert C
SR
Shigeta R
CL
Chan LL
BT
Balschun T
MM
Marconi M
CD
Cusi D
HE
Heathcote EJ
MA
Mason AL
MR
Myers RP
MP
Milkiewicz P
OJ
Odin JA
LV
Luketic VA
BB
Bacon BR
BH
Bodenheimer HC
LV
Liakina V
VC
Vincent C
LC
Levy C
FA
Franke A
GP
Gregersen PK
BF
Bossa F
GM
Gershwin ME
DM
deAndrade M
AC
Amos CI
LK
Lazaridis KN
SM
Seldin MF
SK
Siminovitch KA
Chapter II

Abstract

Summary of the research findings

To further characterize the genetic basis of primary biliary cirrhosis (PBC), we genotyped 2426 PBC patients and 5731 unaffected controls from three independent cohorts using a single nucleotide polymorphism (SNP) array (Immunochip) enriched for autoimmune disease risk loci. Meta-analysis of the genotype data sets identified a novel disease-associated locus near the TNFSF11 gene at 13q14, provided evidence for association at six additional immune-related loci not previously implicated in PBC and confirmed associations at 19 of 22 established risk loci. Results of conditional analyses also provided evidence for multiple independent association signals at four risk loci, with haplotype analyses suggesting independent SNP effects at the 2q32 and 16p13 loci, but complex haplotype driven effects at the 3q25 and 6p21 loci. By imputing classical HLA alleles from this data set, four class II alleles independently contributing to the association signal from this region were identified. Imputation of genotypes at the non-HLA loci also provided additional associations, but none with stronger effects than the genotyped variants. An epistatic interaction between the IL12RB2 risk locus at 1p31and the IRF5 risk locus at 7q32 was also identified and suggests a complementary effect of these loci in predisposing to disease. These data expand the repertoire of genes with potential roles in PBC pathogenesis that need to be explored by follow-up biological studies.

2,216 European ancestry cases, 5,594 Europen ancestry controls

Chapter III

Study Statistics

Key metrics and study information

7810
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Canada, U.S., Italy
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.